Additionally, the CFDA has approved Xarelto for the treatment of deep vein thrombosis (DVT) and for the reduction of the risk of recurrent DVT and pulmonary embolism (PE)
The article details tarextumab’s anti-tumor effects alone and in combination with chemotherapy and elucidates the drug candidate’s mechanisms of activity. Additionally, data is presented describing the basis for
If successful, guanabenz (formerly called MRF-008) could be the first MS treatment to focus on protecting myelin from damage, which is the hallmark of MS, rather than on
The Cranbury facility is designed to utilize multiple technologies that enable rapid deployment of flexible manufacturing at commercial scale. Through the use of the latest single-use technologies, the
"We have already seen good evidence that Luminate can induce PVD in patients with diabetic macular edema," says Baruch Kuppermann, M.D., Ph.D., Professor of Ophthalmology and Biomedical Engineering,
F-652 was demonstrated to be safe in a Phase I study conducted in Australia in healthy volunteers in 2013. In addition, F-652 showed good pharmacokinetic (PK) and biomarker
The research is part of the Semiconductor Synthetic Biology (SSB) program sponsored and managed by Semiconductor Research Corporation (SRC), the world’s leading university-research consortium for semiconductor technologies. Launched
These new data support previously reported positive long-term safety and signs of visual improvement, as presented in The Lancet of October 15th, 2014. The Korean study published online
Lipocine previously announced positive top line efficacy from the SOAR clinical study in September 2014 and expects to announce top-line results from the 52 week safety assessment portion
This process was successfully conducted by the Vancouver Commodities Group (VCG) that had been hired by Nutra Pharma to begin the process of identifying and vetting potential distributors
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.